AU6049099A - Human chorionic gonadotropin vaccines - Google Patents

Human chorionic gonadotropin vaccines

Info

Publication number
AU6049099A
AU6049099A AU60490/99A AU6049099A AU6049099A AU 6049099 A AU6049099 A AU 6049099A AU 60490/99 A AU60490/99 A AU 60490/99A AU 6049099 A AU6049099 A AU 6049099A AU 6049099 A AU6049099 A AU 6049099A
Authority
AU
Australia
Prior art keywords
vaccines
chorionic gonadotropin
human chorionic
gonadotropin
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60490/99A
Inventor
Jeffrey Harris
Mitzi Martinez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repros Therapeutics Inc
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Publication of AU6049099A publication Critical patent/AU6049099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0006Contraceptive vaccins; Vaccines against sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU60490/99A 1998-09-17 1999-09-16 Human chorionic gonadotropin vaccines Abandoned AU6049099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10076698P 1998-09-17 1998-09-17
US60100766 1998-09-17
PCT/US1999/021591 WO2000015253A1 (en) 1998-09-17 1999-09-16 Human chorionic gonadotropin vaccines

Publications (1)

Publication Number Publication Date
AU6049099A true AU6049099A (en) 2000-04-03

Family

ID=22281429

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60490/99A Abandoned AU6049099A (en) 1998-09-17 1999-09-16 Human chorionic gonadotropin vaccines

Country Status (4)

Country Link
EP (1) EP1113814A1 (en)
CN (1) CN1326359A (en)
AU (1) AU6049099A (en)
WO (1) WO2000015253A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201204751D0 (en) * 2012-03-19 2012-05-02 Isis Innovation Immune modulation
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5823847B2 (en) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 Method for producing anti-human protein antibodies
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
PT789590E (en) * 1994-09-23 2002-12-31 Zonagen Inc IMMUNOPOTATION INDUCED BY QUITOSAN

Also Published As

Publication number Publication date
CN1326359A (en) 2001-12-12
EP1113814A1 (en) 2001-07-11
WO2000015253A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
AU9623898A (en) Vaccines
AU3792497A (en) Methods of promoting hematopoiesis using derivatives of human chorionic gonadotropin
AU2001236148A1 (en) Polyorganosilsesquioxane and process for preparing the same
TW493433U (en) Tampax
EP1100011A3 (en) Scriptor and interpreter
AU5020400A (en) Heteroaryloxypyrimidine insecticides and acaricides
EP1083926A4 (en) Vaccine
IL140984A0 (en) Fsh and fsh variant formulations, products and methods
AU3684895A (en) Use of human chorionic gonadotropin as an immune-potentiating agent
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU3159499A (en) Antigen preparation and use
AU3472799A (en) Dermatological formulations and methods
AU3388400A (en) Human glycosylation enzymes
AU1608201A (en) Human zven proteins
AU2841801A (en) Triazolotriazinones and the use thereof
AU5977700A (en) Vaccines
GB9822714D0 (en) Vaccines
GB0027072D0 (en) Vaccine
CZ20011896A3 (en) Immunogenic preparation and antibody
AU6158700A (en) Vaccine
AU3357700A (en) Phenoxypyrimidine insecticides and acaricides
EP1023083A4 (en) Veterinary vaccines
AU6049099A (en) Human chorionic gonadotropin vaccines
AU2227999A (en) Human ependymin
AU4456800A (en) Human hac3

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase